BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Tuesday reported a loss of $24.1 million in its fourth quarter.
On a per-share basis, the Baudette, Minnesota-based company said it had a loss of $1.72. Earnings, adjusted for non-recurring costs and asset impairment costs, were 54 cents per share.
The drugmaker posted revenue of $60.9 million in the period.
For the year, the company reported that its loss widened to $42.6 million, or $3.40 per share. Revenue was reported as $216.1 million.
ANI shares have dropped 23% since the beginning of the year. The stock has climbed 10% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANIP at https://www.zacks.com/ap/ANIP
